U. Speck

INTRAVENOUS CHELATED GADOLINIUM AS A CONTRAST AGENT IN NMR IMAGING OF CEREBRAL TUMOURS

G. Bydder, I. Young, H. Weinmann, 1984, The Lancet.

Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system.

H. Weinmann, W. Press, G. Schuhmann-Giampieri, 1992, Radiology.

Magnesium pyridoxal 5-phosphate glutamate reduces hyperlipidaemia in patients with chronic renal insufficiency

J. Hasford, U. Speck, B. Heintz, 2004, European Journal of Clinical Pharmacology.

MR angiography with gadopentetate dimeglumine-polylysine: evaluation in rabbits.

H. Bosmans, P. Hecke, A. Baert, 1990, AJR. American journal of roentgenology.

NMR imaging study of the pharmacodynamics of polylysine-gadolinium-DTPA in the rabbit and the rat.

H. Bosmans, C. Van Ongeval, A. Baert, 1991, Magnetic resonance imaging.

Influence of guar on serum lipids in patients with hyperlipidaemia

U. Speck, K. Németh, K. Nelson, 2004, European Journal of Clinical Pharmacology.

Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

G M Bydder, A. S. Hall, I R Young, 1984, AJR. American journal of roentgenology.

Influence of two guar preparations on glucose and insulin levels during a glucose tolerance test in healthy volunteers.

U. Speck, J. Storck, K. Nelson, 1991, International journal of clinical pharmacology, therapy, and toxicology.

Pharmacokinetics and pharmacodynamics of mepindolol sulphate.

H. Wendt, W. Krause, U. Speck, 1980, International journal of clinical pharmacology, therapy, and toxicology.